Sanofi (SNY) Long-Term Deferred Tax (2016 - 2025)
Sanofi's Long-Term Deferred Tax history spans 17 years, with the latest figure at $10.0 billion for Q4 2025.
- On a quarterly basis, Long-Term Deferred Tax rose 17.7% to $10.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $10.0 billion, a 17.7% increase, with the full-year FY2025 number at $10.0 billion, up 17.7% from a year prior.
- Long-Term Deferred Tax hit $10.0 billion in Q4 2025 for Sanofi, up from $9.1 billion in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for SNY hit a ceiling of $10.0 billion in Q4 2025 and a floor of $1.4 billion in Q4 2021.
- Historically, Long-Term Deferred Tax has averaged $6.6 billion across 5 years, with a median of $6.7 billion in 2023.
- Biggest five-year swings in Long-Term Deferred Tax: tumbled 72.11% in 2021 and later soared 295.31% in 2022.
- Tracing SNY's Long-Term Deferred Tax over 5 years: stood at $1.4 billion in 2021, then soared by 295.31% to $5.5 billion in 2022, then rose by 25.96% to $6.9 billion in 2023, then grew by 23.12% to $8.5 billion in 2024, then increased by 17.7% to $10.0 billion in 2025.
- Business Quant data shows Long-Term Deferred Tax for SNY at $10.0 billion in Q4 2025, $9.1 billion in Q2 2025, and $8.5 billion in Q4 2024.